Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Family History Not Linked to Clinical Presentation, Treatment Response of RA

Will Boggs, MD  |  July 16, 2015

“Family history of RA is not itself enough to change a clinical decision,” Dr. Frisell said. “We do not yet have evidence enough to be sure if a patient’s family history of response to specific treatments is predictive of treatment response, but our data was in line with this, and it may be expected from several genetic studies.”

Dr. Frisell’s message to patients: “The fact that you have ‘familial’ RA does not mean that you will have a more aggressive disease, or that it will be more difficult to treat.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Jeffrey A. Sparks from Brigham and Women’s Hospital’s division of rheumatology, immunology, and allergy in Boston told Reuters Health by email, “There have been studies that show that familial RA occurs earlier and is more often seropositive, which typically has a more severe disease course. Given the size of this study, I was somewhat surprised that those with family history had fairly similar courses compared to those without family history.”

“However, there might be other differences that family history does not adequately measure or might even improve,” Dr. Sparks said. “For example, those with family history are already familiar with the signs and symptoms of RA so might present earlier when treatment is more effective. However, based on self-reported symptoms prior to RA diagnosis, this did not seem to explain the findings of this study.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Another previous study found that a particular gene controlling immune function was associated with worse outcomes in RA patients,” Dr. Sparks said. “While family history by itself did not correlate with worse outcomes in RA in this study, there may be particular genes or lifestyle factors that might be important in determining the disease course for RA.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:genetic riskgeneticsMethotrexateRheumatoid Arthritis (RA)TNF inhibitors

Related Articles

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    Are We Playing It Safe?

    October 1, 2010

    Tumor necrosis factor alpha inhibition and the risk of solid malignancies

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences